Technetium-99m scintigraphy: More accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies

European Journal of Nuclear Medicine

Volumn 23, Issue 3, 1996, Pages 247-255

  Almers, Sven ^a,b   Granerus, Göran ^b   Franzén, Lennart ^b   Ström, Magnus ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigranulocyte antibodies; Dual tracer studies; Exametazime; Labelled leucocytes; Technetium 99m; Ulcerative colitis

Indexed keywords

GRANULOCYTE ANTIBODY; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ABDOMINAL SCINTISCANNING; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON BIOPSY; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE; MALE; RANDOMIZED CONTROLLED TRIAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; COLITIS, ULCERATIVE; FEMALE; GRANULOCYTES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXIMES; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0029964166     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00837622     Document Type: Article

References (38)

1. Peters AM, Saverymuttu SH. The value of indium-labelled leukocytes in clinical practice. Blood Rev 1987; 1: 65-76.
2. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun 1988; 9: 693-701.
3. Weldon MJ. 99mTc-HMPAO planar white cell scanning. Scand J Gastroenterol 1993; 29 (Suppl 203): 36-42.
4. 99mTcHMPAO-leukocytes for imaging inflammation. Semin Nucl Med 1994; 24: 110-127.
5. Almer S, Franzén L, Peters AM, et al. Do technetium-99m hexamethylpropylene amine oxime (HMPAO) labelled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 1992; 27: 1031-1038.
6. Locher JT, Seybold K, Andres RJ, Schubiger PA, Mach JP, Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocyte antibodies. Nucl Med Commun 1986; 7: 659-670.
7. Lind P, Langsteger W, Költringer P, Dimai HP, Passl R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med 1990; 31: 417-423.
8. 99Tcm granulocyte antibody scan in inflammatory diseases. Nucl Med Commun 1992; 13: 186-192.
9. Sciuk J, Puskás C, Greitemann B, Schober O. White blood cell scintigraphy with monoclonal antibodies in the study of the infected endoprosthesis. Eur J Nucl Med 1992; 19: 497-502.
10. Kroiss A, Weiss W, Auinger C, et al. Immunoscintigraphy (IS) with I-123 and Tc-99m labeled granulocytes antibody (Ab) in patients with inflammatory bowel diseases. In: Sinzinger H, Thakur ML, Eds. Radiolabelled cellular blood elements. New York: Wiley-Liss; 1990: 319-325.
11. Segarra I, Roca M, Baliellas C, et al. Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labelled leucocyte scintigraphy in inflammatory bowel disease. Eur J Nucl Med 1991; 18: 715-719.
12. Mahida YR, Perkins AC, Frier M, Wastie ML, Hawkey CJ. Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun 1992; 13: 330-335.
13. Bosslet K, Lüben G, Schwarz A, et al. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer 1985; 36: 75-84.
14. Maschek W, Neumüller H, Pastl K, et al. Kinetik and immunzytochemische Färbung monoklonaler 99mTc-markierter Anti-CEA-Antikörper gegen Granulozyten nach intravenöser Applikation. Nucl Med 1990; 29: 19-23.
15. Steinsträsser A, Berberich R, Kuhlmann L, Zabori S, Schwarz A. Bindung des monoklonalen Antikörpers BW 250/183 an menschliche Granulozyten. Nucl Med 1992; 31: 57-63.
16. Burtin P, Quan PC, Sabine MC. Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature 1975; 255: 714-716.
17. Wahren B, Gahrton G, Hammarström S. Non-specific cross-reacting antigen in normal and myeloid cells and serum of leukemic patients. Cancer Res 1980; 40: 2039-2044.
18. Bosslet K, Steinsträsser A, Schwarz A, et al. Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J Nucl Med 1988; 14: 523-528.
19. Schwarz A, Steinsträsser A. A novel approach to Tc-99m-labelled monoclonal antibodies [abstract]. J Nucl Med 1987; 28: 721.
20. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; I: 89-92.
21. Ginsberg AL, Beck LS, McIntosh TM, Nochomowitz LE. Treatment of leftsided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med 1988; 108: 195-199.
22. Watts JMcK, Thompson H, Goligher JC. Sigmoidoscopy and cytology in the detection of microscopic disease of the rectal mucosa in ulcerative colitis. Gut 1966; 7: 288-294.
23. Järnerot G, Rolny P, Sandberg-Gertzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005-1013.
24. Becker W, Borst U, Fischbach W, Pasurka B, Schäfer R, Börner W. Kinetic data of in-vivo labeled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody. Eur J Nucl Med 1989; 15: 361-366.
25. 111In-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988; 9: 435-447.
26. Peters AM, Roddie ME, Danpure HJ, et al. Tc-99m HMPAO labelled leukocytes: comparison with In-111 labelled granulocytes. Nucl Med Commun 1988; 9: 449-463.
27. 99Tcm. Nucl Med Commun 1994; 15: 262.
28. Roddie ME, Peters AM, Danpure HJ, et al. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology 1988; 166: 767-772.
29. Groisman GM, George J, Harpaz N. Ulcerative appendicitis in universal and nonuniversal ulcerative colitis. Mod Pathol 1994; 7: 322-325.
30. 99Tcm-labelled monoclonal antibody antibody imaging. Nucl Med Commun 1992; 13: 889-900.
31. Fischbach W, Mössner J, Seyschab H, Höhn H. Tissue carcinoembryonic antigen and DNA aneuploidy in precancerous and cancerous colorectal lesions. Cancer 1990; 65: 1820-1824.
32. Moragas M, Lomena F, Piera C, et al. Antigranulocyte monoclonal antibody (BW 250/183). Kinetics and clinical experience. In: Schmidt HAE, van der Schrott JD, eds. Nuclear medicine: the state of the art of nuclear medicine in Europe. New York: Schattauer; 1991: 145-147.
33. Becker W, Fleig W, Marienhagen J, Hahn E, Wolf F. Diagnostische Bedeutung der intestinalen Aktivität bei der Immunszintigraphie mit Tc-99m-NCA-95-Antikörpern [abstract]. Nucl Med 1990; 29: A30-A31.
34. Lantto EH, Lantto TJ, Vorne M. Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes. J Nucl Med 1991; 32:2029-2034.
35. Costa DC, Lui D, Ell PJ. White cells radiolabelled with 111-In and 99-Tcm - a study of relative sensitivity and in vivo viability. Nucl Med Commun 1988; 9: 725-731.
36. Gibson P, Lichtenstein M, Salehi N, Hebbard G, Andrews J. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. Gut 1991; 32: 1502-1507.
37. Papos M, Nagy F, Nárai G, et al. Immunoscintigraphy with antigranulocyte monoclonal antibody and HMPAO labelled white blood cell scintigraphy in inflammatory bowel disease [abstract]. Eur J Nucl Med 1993; 20: 938.
38. Udby L, Marving J, Høilund-Carlseen PF, Veje A, Vilien M. Diagnostic sensitivity of immune scintigraphy compared to leucocyte scintigraphy in inflammatory bowel disease [abstract]. Gut 1994; 35: A128.